Buffy coat volume reduction for optimization of leucapheresis harvests produced by the autoMNC program

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|108|1|89-95

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.108, Iss.1, 2015-01, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method

By  

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 815-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 1, 2013-01 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

In vitro affinity reduction of biologic response modifiers from production buffy coat platelets exposed to recombinant protein receptors

By  

TRANSFUSION, Vol. 55, Iss. 8, 2015-08 ,pp. : 1919-1926

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 2, 2015-11 ,pp. : 133-136

Karger

Access to resources Recommend Favorite

Buffy coat (top/bottom)‐ and whole‐blood filtration (top/top)‐produced red cell concentrates differ in size of extracellular vesicles

By  

VOX SANGUINIS, Vol. 109, Iss. 3, 2015-10 ,pp. : 214-220

John Wiley & Sons Inc

Access to resources Recommend Favorite